Global Pharmacovigilance Software Market Analysis 2016 - Forecast to 2022

  • ID: 3985566
  • Report
  • Region: Global
  • 147 pages
  • Hoovers Research
1 of 3
This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Pharmacovigilance Software". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America). Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.

Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities.

This report provides:

- Market Sizing estimations and forecasts for 6 years across the given market segments
- Identifying market dynamics (Drivers, Restraints, Opportunities, Threats, Challenges and Opportunities, )
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping of major market players
- Company profiling covering the financials, recent activities and the future strategies
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.4 Market Constraints

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Pharmacovigilance Software Market by End User
5.1 Introduction
5.2 Business Process Outsourcing (BPO) Firms
5.3 Contract Research Organizations (CROS)
5.4 Pharma & biotech companies
5.5 Other End Users

6 Pharmacovigilance Software Market by Delivery Mode
6.1 Introduction
6.2 On-demand
6.3 On-premise

7 Pharmacovigilance Software Market by Functionality
7.1 Introduction
7.2 Issue Tracking Software
7.3 Fully Integrated Software
7.4 Adverse Event Reporting Software
7.5 Drug Safety Audits Software

8 Geographical Segmentation
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Latin America
8.4.2 Middle East
8.4.3 Africa
8.4.4 Others

9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiles
10.1 United Biosource Corporation
10.1.1 Business Overview
10.1.2 SWOT Analysis
10.1.3 Financial Overview
10.1.4 Strategy
10.1.5 Key Activities
10.2 Umbra Global
10.3 Sparta Systems, Inc
10.4 Sarjen Systems Pvt. Ltd
10.5 Oracle Corporation.
10.6 Online Business Applications, Inc
10.7 Extedo GMBH.
10.8 Ennov.
10.9 Arisglobal
10.10 AB-Cube
11 Appendix
12 Disclaimer

List of Tables
Table 1 Global Pharmacovigilance Software Market Analysis, by Region, 2013-2022 ($MN)
Table 2 Global Pharmacovigilance Software Market Analysis, by End User, 2013-2022 ($MN)
Table 3 Global Business Process Outsourcing (BPO) Firms Market Analysis, by Region, 2013-2022 ($MN)
Table 4 Global Contract Research Organizations (CROS) Market Analysis, by Region, 2013-2022 ($MN)
Table 5 Global Pharma & biotech companies Market Analysis, by Region, 2013-2022 ($MN)
Table 6 Global Other End Users Market Analysis, by Region, 2013-2022 ($MN)
Table 7 Global Pharmacovigilance Software Market Analysis, by Delivery Mode, 2013-2022 ($MN)
Table 8 Global On-demand Market Analysis, by Region, 2013-2022 ($MN)
Table 9 Global On-premise Market Analysis, by Region, 2013-2022 ($MN)
Table 10 Global Pharmacovigilance Software Market Analysis, by Functionality, 2013-2022 ($MN)
Table 11 Global Issue Tracking Software Market Analysis, by Region, 2013-2022 ($MN)
Table 12 Global Fully Integrated Software Market Analysis, by Region, 2013-2022 ($MN)
Table 13 Global Adverse Event Reporting Software Market Analysis, by Region, 2013-2022 ($MN)
Table 14 Global Drug Safety Audits Software Market Analysis, by Region, 2013-2022 ($MN)
Table 15 North America Pharmacovigilance Software Market Analysis, by Country, 2013-2022 ($MN)
Table 16 North America Pharmacovigilance Software Market Analysis, by End User, 2013-2022 ($MN)
Table 17 North America Business Process Outsourcing (BPO) Firms Market Analysis, by Country, 2013-2022 ($MN)
Table 18 North America Contract Research Organizations (CROS) Market Analysis, by Country, 2013-2022 ($MN)
Table 19 North America Pharma & biotech companies Market Analysis, by Country, 2013-2022 ($MN)
Table 20 North America Other End Users Market Analysis, by Country, 2013-2022 ($MN)
Table 21 North America Pharmacovigilance Software Market Analysis, by Delivery Mode, 2013-2022 ($MN)
Table 22 North America On-demand Market Analysis, by Country, 2013-2022 ($MN)
Table 23 North America On-premise Market Analysis, by Country, 2013-2022 ($MN)
Table 24 North America Pharmacovigilance Software Market Analysis, by Functionality, 2013-2022 ($MN)
Table 25 North America Issue Tracking Software Market Analysis, by Country, 2013-2022 ($MN)
Table 26 North America Fully Integrated Software Market Analysis, by Country, 2013-2022 ($MN)
Table 27 North America Adverse Event Reporting Software Market Analysis, by Country, 2013-2022 ($MN)
Table 28 North America Drug Safety Audits Software Market Analysis, by Country, 2013-2022 ($MN)
Table 29 Europe Pharmacovigilance Software Market Analysis, by Country, 2013-2022 ($MN)
Table 30 Europe Pharmacovigilance Software Market Analysis, by End User, 2013-2022 ($MN)
Table 31 Europe Business Process Outsourcing (BPO) Firms Market Analysis, by Country, 2013-2022 ($MN)
Table 32 Europe Contract Research Organizations (CROS) Market Analysis, by Country, 2013-2022 ($MN)
Table 33 Europe Pharma & biotech companies Market Analysis, by Country, 2013-2022 ($MN)
Table 34 Europe Other End Users Market Analysis, by Country, 2013-2022 ($MN)
Table 35 Europe Pharmacovigilance Software Market Analysis, by Delivery Mode, 2013-2022 ($MN)
Table 36 Europe On-demand Market Analysis, by Country, 2013-2022 ($MN)
Table 37 Europe On-premise Market Analysis, by Country, 2013-2022 ($MN)
Table 38 Europe Pharmacovigilance Software Market Analysis, by Functionality, 2013-2022 ($MN)
Table 39 Europe Issue Tracking Software Market Analysis, by Country, 2013-2022 ($MN)
Table 40 Europe Fully Integrated Software Market Analysis, by Country, 2013-2022 ($MN)
Table 41 Europe Adverse Event Reporting Software Market Analysis, by Country, 2013-2022 ($MN)
Table 42 Europe Drug Safety Audits Software Market Analysis, by Country, 2013-2022 ($MN)
Table 43 Asia Pacific Pharmacovigilance Software Market Analysis, by Country, 2013-2022 ($MN)
Table 44 Asia Pacific Pharmacovigilance Software Market Analysis, by End User, 2013-2022 ($MN)
Table 45 Asia Pacific Business Process Outsourcing (BPO) Firms Market Analysis, by Country, 2013-2022 ($MN)
Table 46 Asia Pacific Contract Research Organizations (CROS) Market Analysis, by Country, 2013-2022 ($MN)
Table 47 Asia Pacific Pharma & biotech companies Market Analysis, by Country, 2013-2022 ($MN)
Table 48 Asia Pacific Other End Users Market Analysis, by Country, 2013-2022 ($MN)
Table 49 Asia Pacific Pharmacovigilance Software Market Analysis, by Delivery Mode, 2013-2022 ($MN)
Table 50 Asia Pacific On-demand Market Analysis, by Country, 2013-2022 ($MN)
Table 51 Asia Pacific On-premise Market Analysis, by Country, 2013-2022 ($MN)
Table 52 Asia Pacific Pharmacovigilance Software Market Analysis, by Functionality, 2013-2022 ($MN)
Table 53 Asia Pacific Issue Tracking Software Market Analysis, by Country, 2013-2022 ($MN)
Table 54 Asia Pacific Fully Integrated Software Market Analysis, by Country, 2013-2022 ($MN)
Table 55 Asia Pacific Adverse Event Reporting Software Market Analysis, by Country, 2013-2022 ($MN)
Table 56 Asia Pacific Drug Safety Audits Software Market Analysis, by Country, 2013-2022 ($MN)
Table 57 RoW Pharmacovigilance Software Market Analysis, by Country, 2013-2022 ($MN)
Table 58 RoW Pharmacovigilance Software Market Analysis, by End User, 2013-2022 ($MN)
Table 59 RoW Business Process Outsourcing (BPO) Firms Market Analysis, by Country, 2013-2022 ($MN)
Table 60 RoW Contract Research Organizations (CROS) Market Analysis, by Country, 2013-2022 ($MN)
Table 61 RoW Pharma & biotech companies Market Analysis, by Country, 2013-2022 ($MN)
Table 62 RoW Other End Users Market Analysis, by Country, 2013-2022 ($MN)
Table 63 RoW Pharmacovigilance Software Market Analysis, by Delivery Mode, 2013-2022 ($MN)
Table 64 RoW On-demand Market Analysis, by Country, 2013-2022 ($MN)
Table 65 RoW On-premise Market Analysis, by Country, 2013-2022 ($MN)
Table 66 RoW Pharmacovigilance Software Market Analysis, by Functionality, 2013-2022 ($MN)
Table 67 RoW Issue Tracking Software Market Analysis, by Country, 2013-2022 ($MN)
Table 68 RoW Fully Integrated Software Market Analysis, by Country, 2013-2022 ($MN)
Table 69 RoW Adverse Event Reporting Software Market Analysis, by Country, 2013-2022 ($MN)
Table 70 RoW Drug Safety Audits Software Market Analysis, by Country, 2013-2022 ($MN)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll